Global Catheters and Cannulas Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
Catheters are thin, flexible tubes that carry fluids into and out of a person's body. When a patient comes into the hospital, a catheter is sometimes inserted to ensure that any necessary intravenous drugs, blood products, or fluids can be given quickly, and is also used to pass through the urethra into the bladder to drain urine. Cannulas are tubes that are inserted into the body to drain fluids or introduce medications. They can be placed in a nasal cannula to get oxygen or in an IV cannula to draw fluids or give medicines. Catheters and cannulas are an essential part of modern medicine.
Market Overview:The latest research study on the global Catheters and Cannulas market finds that the global Catheters and Cannulas market reached a value of USD 36125.0 million in 2022. It’s expected that the market will achieve USD 48897.0 million by 2028, exhibiting a CAGR of 5.17% during the forecast period.
Post-COVID-19 Catheters and Cannulas Industry Opportunity
In the early stage of the epidemic, the blockade of many countries and regions led to the temporary and postponement of educational activities in universities and projects of some research institutions, which reduced the demand for Catheters and Cannulas and related equipment to a certain extent. But there has been a surge in demand from hospitals and related medical research institutes. In particular, there has been a historic increase in the demand for laboratory equipment as the development and production of COVID-19-related tests and vaccines ramps up rapidly. As a result, many industry players have been quick to collaborate with governments, public health agencies, and other industries during the pandemic to ramp up production capacity at Catheters and Cannulas production facilities to meet growing customer demand and address the growing threat of COVID. At the same time, companies are paying more attention to improving automation capabilities and optimizing storage and disinfection capabilities to improve the agility of the supply chain.
The pandemic has drawn attention to the urgent need to prevent infection. In the intervening years, many governments have stepped up investment in the manufacture of Catheters and Cannulas for COVID-19 testing, helping manufacturers to specialize their manufacturing equipment to ensure the establishment of fully automated production lines. Currently, these products remain in high demand from diagnostic laboratories and vaccine manufacturers around the world working on COVID-19 vaccines or conducting tests for SARS CoV-2 due to the need for sterile drug development procedures and limited doses. Furthermore, several Catheters and Cannulas manufacturers are favorably driving the market growth by developing products for enhanced protection against secondary infections. In 2021, Health Canada approved the Bactiguard urinary catheter with a temperature sensor, which can reduce the incidence of secondary infections in critically ill patients.
Technology progress
Biomedical Materials Technology
Medical catheters and cannulas rely on the development of basic materials, especially closely related to the development level of biomedical materials. In addition to meeting the basic requirements of clinical medicine such as non-toxicity, non-carcinogenicity, non-allergic, and non-deformation, biomedical materials also have good biocompatibility with the human body, good biocompatibility, and non-distortion. Multiple requirements such as stability and physical and mechanical properties compatible with natural tissues. At present, synthetic polymer medical materials are widely used in medical catheters and intubation biomedical materials. Through molecular design or modification with special formulas, the production materials can obtain good physical, mechanical and biocompatibility. For example, medical catheter companies that use balloons in their products are constantly developing high-performance balloon materials, so that the balloon has the characteristics of high elongation at break, high strength, and low deformation, ensuring that the material can still maintain a relatively thin state in an ultra-thin state. Strong physical mechanics and good biocompatibility to ensure the best clinical utility.
Surface coating technology
With the gradual stabilization of technology, surface coating technology is increasingly used in the production of catheters and cannulas. After using the antibacterial surface coating technology on the catheter and cannula, the product has anti-infection properties while maintaining the original function, which not only reduces the chance of infection, reduces the use of antibiotics, but also simplifies the treatment and nursing process. After the use of biological surface coating technology for catheters and cannulas, while maintaining the original functions, the products have better biocompatibility, anti-coagulation and lubricating properties, effectively improving the functions and performance of the products.
Increased prevalence of cardiovascular, neurological and urological disorders
Over the past few decades, cardiovascular, urological and neurological diseases have become one of the most important contributors to morbidity and mortality worldwide. People who are sedentary are more likely to suffer from various chronic diseases, including diabetes, cardiovascular disease (CVD), urinary system diseases, etc. Hypertension and diabetes are important contributors to the rising incidence of chronic diseases such as kidney failure, one of the most serious consequences of this trend. Most kidney diseases are caused by conditions such as urinary tract infections, glomerulonephritis, polycystic kidney disease, lupus, and other kidney malformations. Insufficient physical activity, excessive alcohol consumption, smoking, obesity, and inconsistent diet lead to an increase in cardiovascular and neurovascular diseases. As these diseases become common, more people will require the use of catheters, thereby driving the demand throughout the forecast period. In addition, end-stage renal disease is associated with high hospitalization rates and large costs because its treatment requires dialysis catheters. Rising prevalence of chronic diseases leading to rising hospitalization rates is expected to boost adoption of catheters, thereby driving market growth.
Region Overview:In 2022, the share of the Catheters and Cannulas market in North America stood at 35.40%.
Company Overview:The major players operating in the Catheters and Cannulas market include Medtronic, BD, B. Braun, Coloplast, Terumo, etc. Among which, Medtronic ranked top in terms of sales and revenue in 2023.
Medtronic
Medtronic, Inc. provides medical devices. The Company offers surgical devices, medical instruments, apparatus, respiratory monitoring systems, medical supplies, and other equipment.
BD
BD is a global medical technology company engaged principally in the development, manufacture, and sale of medical devices, instrument systems, and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public.
Segmentation Overview:By type, Catheters segment accounted for the largest share of market in 2022.
Application Overview:By application, the Hospitals segment occupied the biggest share from 2018 to 2022.
Key Companies in the global Catheters and Cannulas market covered in Chapter 3:Medtronic
Abbott
ConvaTec
Well Lead Medical
Fresenius
Terumo
Hollister
Coloplast
Teleflex
Cook Medical
B. Braun
BD
ICU Medical
Tuoren Medical
Boston Scientific
Medline
In Chapter 4 and Chapter 14.2, on the basis of types, the Catheters and Cannulas market from 2018 to 2029 is primarily split into:Catheters
Cannulas
In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Catheters and Cannulas market from 2018 to 2029 covers:Hospitals
Ambulatory Surgical Centers
Long-term Care Facilities
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)